Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
INTEGRATED BIOPHARMA INC
| Metric | INTEGRATED BIOPHARMA INC INBPHealthcare |
|---|---|
| Quality Score | 93 / 100 |
| Revenue (latest) | $54M |
| Net income (latest) | $808,000 |
| Operating margin | 3.7% |
| Net margin | 1.5% |
| Return on equity | 4.0% |
| Return on assets | 3.2% |
| Return on capital (ROCE) | 9.8% |
| Debt / equity | 0.23× |
| Revenue growth (YoY) | 8.0% |
| Altman Z″ (distress) | 4.91 |
| Accruals / assets | −5.0% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.